Banasco, Rubie P.

HRN: 18-52-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2026
MUPIROCIN 2%, 15G (TUBE)
06/16/2026
06/22/2026
TOPICAL
2%
OD
SP CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines